Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Symeonidis

Showing results (561-570 of 578) with videos related to

Pageof 58
Sort By:
Blood|October 26, 2014
Recurrent ETNK1 mutations in atypical chronic myeloid leukemiaCarlo B Gambacorti-Passerini, Carla Donadoni, Andrea Parmiani, et al.
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Haematologica|July 7, 2019
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registryMarlijn Hoeks, Ge Yu, Saskia Langemeijer, et al.
Blood Advances|August 26, 2020
Guideline-based indicators for adult patients with myelodysplastic syndromesKristina Stojkov, Tobias Silzle, Georg Stussi, et al.
Blood Cells, Molecules & Diseases|March 10, 2017
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher diseaseM Biegstraaten, T M Cox, N Belmatoug, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
Science Immunology|March 1, 2024
TGF-β specifies T<sub>FH</sub> versus T<sub>H</sub>17 cell fates in murine CD4<sup>+</sup> T cells through c-MafYinshui Chang, Luisa Bach, Marko Hasiuk, et al.
Hemasphere|January 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromesDavid Rombaut, Sarah Sandmann, Tobias Tekath, et al.
The Lancet. Haematology|January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort studyLisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
Annals of Hematology|February 1, 2021
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategiesTheodoros P Vassilakopoulos, Sotirios G Papageorgiou, Maria K Angelopoulou, et al.
Pageof 58

Showing results (561-570 of 578) with videos related to

Sort By:
Pageof 58
Blood|October 26, 2014
Recurrent ETNK1 mutations in atypical chronic myeloid leukemiaCarlo B Gambacorti-Passerini, Carla Donadoni, Andrea Parmiani, et al.
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Haematologica|July 7, 2019
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registryMarlijn Hoeks, Ge Yu, Saskia Langemeijer, et al.
Blood Advances|August 26, 2020
Guideline-based indicators for adult patients with myelodysplastic syndromesKristina Stojkov, Tobias Silzle, Georg Stussi, et al.
Blood Cells, Molecules & Diseases|March 10, 2017
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher diseaseM Biegstraaten, T M Cox, N Belmatoug, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
Science Immunology|March 1, 2024
TGF-β specifies T<sub>FH</sub> versus T<sub>H</sub>17 cell fates in murine CD4<sup>+</sup> T cells through c-MafYinshui Chang, Luisa Bach, Marko Hasiuk, et al.
Hemasphere|January 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromesDavid Rombaut, Sarah Sandmann, Tobias Tekath, et al.
The Lancet. Haematology|January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort studyLisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
Annals of Hematology|February 1, 2021
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategiesTheodoros P Vassilakopoulos, Sotirios G Papageorgiou, Maria K Angelopoulou, et al.
Pageof 58